| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Wistar Institute of Anatomy and Biology, 36th Street at Spruce, Philadelphia, Pennsylvania 19104, U.S.A.
Antigenic variation in the glycoprotein of rabies (CVS-11) virus was studied. Neutralization-resistant variant viruses were isolated in vitro at high frequency (10-4 to 10-5) in the presence of anti-glycoprotein monoclonal antibody. Analysis of these variants identified at least three functionally independent antigenic sites, based on the grouping of variants that were no longer neutralized by one or more of a panel of 24 monoclonal antibodies. Competition radioimmunoassay suggested that one of these three antigenic sites was topologically distinct, with the other two in close proximity. In addition, it was shown that most (but not all) neutralization-resistant variants failed to bind the relevant monoclonal antibody. Viruses with altered antigenicity were shown to accumulate in virus stocks following several passages in vitro in the absence of antibody. In addition, variants were isolated in vivo following treatment of mice with monoclonal antibody.
Keywords: rabies virus glycoprotein, monoclonal Ab, antigenic variation, neutralization
Received 14 September 1982;
accepted 1 December 1982.
This article has been cited by other articles:
|
|
 |
|
  L. Sissoeff, M. Mousli, P. England, and C. Tuffereau Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor J. Gen. Virol., September 1, 2005; 86(9): 2543 - 2552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. H. Bakker, W. E. Marissen, R. A. Kramer, A. B. Rice, W. C. Weldon, M. Niezgoda, C. A. Hanlon, S. Thijsse, H. H. J. Backus, J. de Kruif, et al. Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants J. Virol., July 15, 2005; 79(14): 9062 - 9068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Wojczyk, N. Takahashi, M. T. Levy, D. W. Andrews, W. R. Abrams, W. H. Wunner, and S. L. Spitalnik N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule Glycobiology, June 1, 2005; 15(6): 655 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Marissen, R. A. Kramer, A. Rice, W. C. Weldon, M. Niezgoda, M. Faber, J. W. Slootstra, R. H. Meloen, M. Clijsters-van der Horst, T. J. Visser, et al. Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis J. Virol., April 15, 2005; 79(8): 4672 - 4678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Irie and A. Kawai Studies on the different conditions for rabies virus neutralization by monoclonal antibodies #1-46-12 and #7-1-9 J. Gen. Virol., December 1, 2002; 83(12): 3045 - 3053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Langevin and C. Tuffereau Mutations Conferring Resistance to Neutralization by a Soluble Form of the Neurotrophin Receptor (p75NTR) Map outside of the Known Antigenic Sites of the Rabies Virus Glycoprotein J. Virol., October 2, 2002; 76(21): 10756 - 10765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Maillard and Y. Gaudin Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type J. Gen. Virol., June 1, 2002; 83(6): 1465 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Walker and K Kongsuwan Deduced structural model for animal rhabdovirus glycoproteins J. Gen. Virol., May 1, 1999; 80(5): 1211 - 1220. [Abstract]
|
|
|
|
|
|
C. Jallet, Y. Jacob, C. Bahloul, A. Drings, E. Desmezieres, N. Tordo, and P. Perrin Chimeric Lyssavirus Glycoproteins with Increased Immunological Potential J. Virol., January 1, 1999; 73(1): 225 - 233. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
